AzTrials
AzTrials

Apical PeriodontitisNCT06005545

A Study to Compare Various Root Canal Cleaning Devices Based on Cavitation,Ultrasonic and Conventional Methods.

A study testing Passive Ultrasonic Irrigation (PUI) group, Endoclean (EC) group and Conventional group in people with Apical Periodontitis, run by Lumendo AG at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare the effectiveness of various root canal cleaning devices based on the principle of cavitation, ultrasonics, and conventional methods in a normal healthy adult population aged between 18 to 75 years requiring root canal treatment. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Apical Periodontitis
What is being tested?
Passive Ultrasonic Irrigation (PUI) group, Endoclean (EC) group and Conventional group
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
109 participants
Where
1 siteTurkey (Türkiye)
Study dates
4 Oct 2023to Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • •Patients aged between 18-75 years with ASA (American Society of Anesthesiologists) classification 1 and 2.
  • ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body mass index) under 30, a non-smoking patient with good exercise tolerance.
  • ASA 2: A patient with mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker).
  • Patients who agreed to participate and who have signed the informed consent.
  • Patients presenting with symptomatic and/or asymptomatic apical periodontitis and radiographic evidence of apical periodontitis in anterior or posterior teeth larger than 1.5 mm in diameter.
  • Mature tooth with closed apices
  • Tooth that has never been treated with root canal therapy.

Who cannot join

  • Patients, who have pre-existing health or oral conditions that placed them at risk during the trial.
  • Patients with generalized untreated periodontal disease.
  • Patients with a history of analgesic intake within the past 3 days or antibiotics in the last 1 month.
  • Uncooperative patients
  • Teeth with immature apices, root resorption, or requiring extensive prosthetic rehabilitation.
  • Teeth that cannot be made functional nor restored or difficult to access teeth with no importance (wisdom teeth)
Show all 13Show fewer
  • Teeth with insufficient periodontal support
  • Teeth with poor prognosis, for example due to deep root caries, large root resorption or open apex cases
  • Fractured teeth
  • Local anatomical factors such as an inaccessible root end.
  • Presence of fractured instrument in the root canal
  • Pregnant women
  • Patients unable to understand the study procedure.

Trial locations and contacts

1 site in 1 country.

Tan Fırat Eyüboglu Assoc. Prof. contact

+90 530 463 60 59

tfeyuboglu@yahoo.com

Turkey (Türkiye)1 site, 1 recruiting
  • İstanbul Medipol Universitesi, Faculty of Dentistry, Department of Endodontics

    Istanbul, Unkapanı, Fatih, 34083

    Tan Firat EYÜBOĞLU, DDS, PhD, +90 530 463 6059, tfeyuboglu@yahoo.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: A Comparative Evaluation of Effectiveness in Root Canal Debridement Using Inertial Cavitation Device vs Passive Ultrasonic Irrigation and Conventional Preparation: A Randomized Controlled Clinical Trial

The goal of this clinical trial is to compare the effectiveness of various root canal cleaning devices based on the principle of cavitation, ultrasonics, and conventional methods in a normal healthy adult population aged between 18 to 75 years requiring root canal treatment.

The main question[s] it aims to answer are:

  • Effectiveness of the cleaning mechanism
  • Evaluate the safety of use of the device. Participants will be provided root canal treatment. Participants will be asked to record their post-operative pain levels in a Patient Pain diary. The healing rate of the lesion will be examined at follow-up visits using intraoral X-rays. At the end of the study, a statistical analysis of the clinical outcomes of the root canal treatment will be examined and evaluated in every group.
Read the detailed description

Study title: "A Comparative Evaluation of Effectiveness in Root Canal Debridement using Inertial Cavitation Device vs Passive Ultrasonic Irrigation and Conventional Preparation: A Randomized Controlled Clinical Trial".

Study Design: This is a prospective, 3-arm randomized, non-blinded, single-center pivotal clinical investigation, performed to evaluate the effectiveness and safety of the Endoclean device with 2 comparator arms.

Primary objective: To test the effectiveness of the Endoclean device for root canal debridement up to 12-month follow-up.

Secondary objective: To test the extended effectiveness and safety of the Endoclean device up to a 24-month follow-up.

Inclusion/Exclusion Criteria:

  1. Inclusion Criteria •Patients aged between 18-75 years with ASA (American Society of Anesthesiologists) classification 1 and 2. ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body mass index) under 30, a non-smoking patient with good exercise tolerance. ASA 2: A patient with mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker).
  • Patients who agreed to participate and who have signed the informed consent.
  • Patients presenting with symptomatic and/or asymptomatic apical periodontitis and radiographic evidence of apical periodontitis in anterior or posterior teeth larger than 1.5 mm in diameter.
  • Mature tooth with closed apices
  • Tooth that has never been treated with root canal therapy.
  1. Exclusion Criteria:
  • Patients, who have pre-existing health or oral conditions that placed them at risk during the trial.
  • Patients with generalized untreated periodontal disease.
  • Patients with a history of analgesic intake within the past 3 days or antibiotics in the last 1 month.
  • Uncooperative patients
  • Teeth with immature apices, root resorption, or requiring extensive prosthetic rehabilitation.
  • Teeth that cannot be made functional nor restored or difficult to access teeth with no importance (wisdom teeth)
  • Teeth with insufficient periodontal support
  • Teeth with poor prognosis, for example due to deep root caries, large root resorption or open apex cases
  • Fractured teeth
  • Local anatomical factors such as an inaccessible root end
  • Presence of fractured instrument in the root canal
  • Pregnant women
  • Patients unable to understand the study procedure.

Number of Participants:

Total number of participants = 109 subjects Arm 1: 40 subjects Arm 2: 40 subjects Arm 3: 29 subjects Test device: Endoclean (Lumendo AG): hydraulic cavitation cleaning device Control device 1: Passive ultrasonic irrigation (PUI) Control device 2: Rotary files with standard NaOCl irrigation Study duration: 2-3 years The results of the Endoclean group shall be compared to data gathered from the comparator device groups and results shall be presented in the clinical investigation report.

Being tested
Passive Ultrasonic Irrigation (PUI) group, Endoclean (EC) group, Conventional group
Keywords
Root Canal Treatment, Endodontic Treatment, Root Canal Debridement
Medical subject headings
Periapical Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Passive Ultrasonic Irrigation (PUI) groupDevice

    Also called Ultrasonic group

    Passive ultrasonic irrigation is the current golden standard in root canal cleaning and irrigation devices. It is used after root canal shaping using manual or rotary instruments. It uses sodium hypochlorite which is mobilized in the canal using ultrasonic non-cutting tips to clean, debride, disinfect, and prepare the root canal for obturation.

  • Endoclean (EC) groupDevice

    Also called Cavitation group

    Endoclean is a novel device that uses hydraulic inertial cavitation with the help of pressure and saline solution to debride the root canal after minimal shaping using manual or rotary shaping instruments. It is used to effectively clean, debride and prepare the root canal before obturation in the root canal treatment procedure.

  • Conventional groupDevice

    Conventional root canal preparation uses manual or rotary files along with manual irrigation using syringes and irrigant solutions like sodium hypochlorite or EDTA to clean, debride and prepare the root canal for obturation.

Study groups in NCT06005545
Study groupRoleWhat they receive
Passive Ultrasonic Irrigation group (PUI)Active comparatorArm 1: Passive ultrasonic irrigation group (PUI); shaping up to WL with 25.06,
Receives: Device: Passive Ultrasonic Irrigation (PUI) group
Endoclean group (EC)ExperimentalArm 2: Endoclean (EC) group; shaping up to WL with 20.06; EC application tip kept 3mm short of WL, irrigation protocol with NaOCl (sodium hypochlorite)
Receives: Device: Endoclean (EC) group
Conventional GroupActive comparatorArm 3: Conventional group; shaping up to WL of 25.06, irrigation protocol with NaOCl (sodium hypochlorite)
Receives: Device: Conventional group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary effectiveness endpoint

    Successful healing of periapical lesion up to 12 months post-procedure where success is defined as completely healed or healing lesion with absence of clinical symptoms.

    Healing is assessed by measuring the reduction in periapical lesion radiolucency, up to 12 months post-procedure, using the PAI (periapical index score).

    The absence of clinical symptoms is defined as:

    1. The patient had no discomfort in treated tooth
    2. The patient had no percussive pain during the examination in treated tooth

    Measured: 12 months

Secondary outcomes (2)
  1. Safety endpoint

    Freedom from postoperative pain up to 7 days of follow-up period (24 hours, 48 hours, 72 hours, 7 days and 1 month). Pain is measured by Visual Analogue Scale (VAS) assessment.The visual analogue scale (VAS) is a scale used to determine the pain intensity experienced by individuals. It consists of a line, approximately 10-15 cm in length, with the left side signifying no pain with a smiling face image and the right side signifying the worst pain ever with a frowning face image. The VAS is used to assist individuals to determine pain levels, who may not be accustomed to rating their pain on other types of scales, such as a numeric rating scale.

    Measured: 1 month

  2. Secondary effectiveness endpoints

    Successful healing of periapical lesion up to 24 months post-procedure. Long-term effectiveness success shall be defined as a continued reduction or complete absence of periapical lesion radiolucency at 24m FU since the procedure with no clinical symptoms (i.e no discomfort in treated tooth and no percussive pain during examination)

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2023
  2. Study start4 Oct 2023
  3. Primary completionMar 2025 (estimated)
  4. Study completionMar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a prospective, 3- arm randomized, non-blinded, single center pivotal clinical investigation, performed to evaluate the effectiveness and safety of the Endoclean device with 2 comparator arms. Arm 1: Passive ultrasonic irrigation group (PUI); shaping up to WL with 25.06, Arm 2: Endoclean (EC) group; shaping up to WL with 20.06; EC application tip kept 3mm short of WL, irrigation protocol with NaOCl (sodium hypochlorite) Arm 3: Conventional group; shaping up to WL of 25.06, irrigation protocol with NaOCl (sodium hypochlorite)
Masking
None (open label)
Enrolment
109 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06005545
Sponsor's protocol ID
EC_5301_V1.0_CIP
Status last verified
Dec 2023
First submitted
8 Aug 2023
Last updated
6 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Passive Ultrasonic Irrigation (PUI) group, Endoclean (EC) group and Conventional group in people with Apical Periodontitis, run by Lumendo AG at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tan Fırat Eyüboglu Assoc. Prof. (+90 530 463 60 59, tfeyuboglu@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary effectiveness endpoint (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in